Related Experiment Video
Updated: May 24, 2026
14:51
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
[Risk-adapted therapy in acute myeloid leukemia].
1Medizinische Klinik und Poliklinik III, Campus Großhadern, Klinikum der Ludwig-Maximilians-Universität München.
Der Internist
|March 14, 2012
Summary
Understanding chromosomal and molecular aberrations in acute myeloid leukemia (AML) improves prognosis and guides therapy. Individualized risk profiles, including patient factors, optimize AML treatment strategies.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Context:
- Acute myeloid leukemia (AML) pathogenesis is increasingly understood through genetic and molecular analysis.
- Chromosomal and molecular aberrations are key drivers in AML development.
- Prognostic and therapeutic decisions in AML require comprehensive patient data.
Purpose:
- To elucidate the role of chromosomal and molecular aberrations in acute myeloid leukemia (AML).
- To correlate genetic findings with patient prognosis and treatment response.
- To establish a framework for individualized risk stratification in AML management.
Summary:
- Advances in identifying chromosomal and molecular aberrations have significantly enhanced the understanding of acute myeloid leukemia (AML) pathogenesis.
- These aberrations are crucial for predicting patient prognosis and directing appropriate therapeutic strategies.
- Integrating genetic data with patient-specific factors (age, co-morbidity, performance status) allows for personalized risk profiling.
Impact:
- Improved diagnostic accuracy for acute myeloid leukemia (AML).
- Enhanced ability to predict treatment outcomes and patient survival.
- Facilitation of personalized medicine approaches in AML therapy selection.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications